Boston Medical Products

Executive Summary

Boston Medical Products, Inc., established in 1986 and headquartered in Boston, MA, is a privately held medical device manufacturer renowned as the sole authorized global producer of the Original Montgomery® Brand Products. The company specializes in ENT surgical and respiratory devices, including airway stents, laryngeal prostheses, and pleurodesis products, all designed by physicians to enhance patient outcomes. With a focused portfolio addressing critical needs in airway management and thoracic procedures, Boston Medical Products has built a strong reputation for quality and innovation in the niche ENT and respiratory device market. Its products are widely used in hospitals and surgical centers, supported by decades of clinical expertise. Despite being privately held, Boston Medical Products is well-positioned to capitalize on the growing demand for minimally invasive ENT procedures and the increasing prevalence of respiratory conditions. The company’s established brand and physician-developed product line provide a competitive moat, while potential expansion into new geographies or adjacent therapeutic areas could drive growth. However, limited public information on financials and pipeline makes conviction moderate. Key upside catalysts include regulatory clearances for next-generation devices and strategic partnerships to broaden market access.

Upcoming Catalysts (preview)

• Q3 2026FDA 510(k) Clearance for Next-Generation Montgomery Airway Stent80% success
• TBDStrategic Distribution Partnership with Major ENT Hospital Network60% success
• Q1 2027Expansion of Pleurodesis Product Line into European Markets55% success